Aurora Investment Counsel’s AstraZeneca AZN Stock Holding History

Aurora Investment Counsel’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.53M	Buy	+12,834	New	+$2.47M	1.4%	16
2025 Q4	–	Sell	-18,213	Closed	-$2.79M	–	107
2025 Q3	$2.79M	Sell	18,213 -130	-0.7%	-$19.7K	1.46%	10
2025 Q2	$2.56M	Buy	18,343 +225	+1%	+$31.5K	1.35%	15
2025 Q1	$2.66M	Sell	18,118 -200	-1%	-$28.9K	1.48%	12
2024 Q4	$2.4M	Buy	18,318 +1,425	+8%	+$200K	1.31%	20
2024 Q3	$2.63M	Sell	16,893 -2,587	-13%	-$418K	1.42%	11
2024 Q2	$3.04M	Sell	19,480 -1,378	-7%	-$207K	1.78%	2
2024 Q1	$2.83M	Buy	20,858 +2,687	+15%	+$356K	1.62%	2
2023 Q4	$2.54M	Buy	18,171 +352	+2%	+$45.8K	1.65%	1
2023 Q3	$2.41M	Buy	+17,819	New	+$2.43M	1.6%	1

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Aurora Investment Counsel's AZN Position: Q1 2026 in Review

Aurora Investment Counsel opened a new position in AstraZeneca (AZN) in Q1 2026: 12,834 shares worth $2.53M. The stake represents 1.4% of the portfolio and ranks #16 among its holdings. This is a return to the name: Aurora Investment Counsel previously reported a position in AZN as recently as Q3 2025.

Aurora Investment Counsel first reported a position in AZN in Q3 2023 and has held it in 10 quarters since. The position peaked at $3.04M in Q2 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Aurora Investment Counsel held 12,834 shares of AstraZeneca worth $2.53M as of Q1 2026.
AstraZeneca was a new Aurora Investment Counsel position in Q1 2026.
AstraZeneca made up 1.4% of Aurora Investment Counsel's portfolio in Q1 2026, its #16 holding.
Aurora Investment Counsel first reported a position in AstraZeneca in Q3 2023 and has held it in 10 quarters since.
Aurora Investment Counsel's AstraZeneca position peaked at $3.04M in Q2 2024.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Aurora Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.